Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F92KX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,441
Award facts
- Contract value 100% obligated
- $48,441.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $48,441.26 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for SKYRIZI 150 MG/ML (risankizumab injectable), with a completion date of April 30, 2026.
The order is placed against a DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside.
Quick answers
Who was awarded contract SPE2DR26F92KX?
SPE2DR26F92KX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 29, 2026.
How much is contract SPE2DR26F92KX worth?
The government has obligated $48,441 on SPE2DR26F92KX.
Is contract SPE2DR26F92KX an order under another contract?
Yes. SPE2DR26F92KX is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F92KX competed?
The extent of competition for SPE2DR26F92KX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award